We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVZ icon
1201
Invesco
IVZ
$13.4B
$396K ﹤0.01%
+20,486
New +$383K
MODN
1202
DELISTED
MODEL N, INC.
MODN
$395K ﹤0.01%
+22,511
New +$360K
RIO icon
1203
Rio Tinto
RIO
$148B
$393K ﹤0.01%
+6,676
New +$367K
BVH
1204
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$393K ﹤0.01%
+13,289
New +$407K
AVAL icon
1205
Grupo Aval
AVAL
$5.73B
$392K ﹤0.01%
50,364
-136,320
-73% -$980K
HRTG icon
1206
Heritage Insurance Holdings
HRTG
$865M
$389K ﹤0.01%
+26,668
New +$394K
KDMN
1207
DELISTED
Kadmon Holdings, Inc.
KDMN
$389K ﹤0.01%
147,362
+114,108
+343% +$288K
WMT icon
1208
Walmart Inc
WMT
$889B
$388K ﹤0.01%
11,940
-285,513
-96% -$9.26M
ZION icon
1209
Zions Bancorporation
ZION
$10.1B
$388K ﹤0.01%
8,541
-122,922
-94% -$5.86M
LASR icon
1210
nLIGHT
LASR
$3.72B
$379K ﹤0.01%
+17,017
New +$344K
TXT icon
1211
Textron
TXT
$16.8B
$377K ﹤0.01%
7,453
-9,075
-55% -$468K
NVRO
1212
DELISTED
NEVRO CORP.
NVRO
$376K ﹤0.01%
6,024
-20,019
-77% -$941K
CMLS
1213
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$374K ﹤0.01%
+20,794
New +$320K
CWCO icon
1214
Consolidated Water Co
CWCO
$470M
$373K ﹤0.01%
28,979
+23,373
+417% +$300K
HBIO icon
1215
Harvard Bioscience
HBIO
$27.1M
$373K ﹤0.01%
8,654
+7,409
+595% +$269K
CAMT icon
1216
Camtek
CAMT
$6.82B
$372K ﹤0.01%
41,706
+27,176
+187% +$220K
KURA icon
1217
Kura Oncology
KURA
$937M
$372K ﹤0.01%
+22,440
New +$346K
RDUS
1218
DELISTED
Radius Health, Inc.
RDUS
$371K ﹤0.01%
+18,582
New +$339K
TDAY
1219
USA Today Co
TDAY
$1.25B
$370K ﹤0.01%
+35,234
New +$452K
DLTH icon
1220
Duluth Holdings
DLTH
$163M
$366K ﹤0.01%
+15,346
New +$365K
VRS
1221
DELISTED
Verso Corporation
VRS
$365K ﹤0.01%
17,040
-256,759
-94% -$5.92M
BHVN
1222
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$365K ﹤0.01%
+7,098
New +$307K
IVW icon
1223
iShares S&P 500 Growth ETF
IVW
$72.2B
$363K ﹤0.01%
8,416
+3,004
+56% +$123K
FIVE icon
1224
Five Below
FIVE
$11.3B
$362K ﹤0.01%
2,912
-162,087
-98% -$19.6M
QSR icon
1225
Restaurant Brands International
QSR
$25.4B
$361K ﹤0.01%
5,551
-180,146
-97% -$11.1M

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.